Literature DB >> 3966895

DNA flow cytometry of thyroid neoplasms.

B B Kraemer, J R Srigley, J G Batsakis, E G Silva, H Goepfert.   

Abstract

Mechanically dispersed cell suspensions from 23 thyroid lesions were studied by acridine orange flow cytometry. Eight of 14 carcinomas (three papillary, two medullary, two Hürthle cell, and one follicular) manifested abnormal DNA indices ranging from 0.6 to 2.0. Six carcinomas (four papillary and two medullary) were diploid. Four patients having papillary carcinomas with diploid DNA content were young women whose clinical course of disease was indolent. Three papillary carcinomas with abnormal DNA content were found in older men with clinically aggressive disease. One benign adenomatoid nodule displayed a small population with a low-degree hyperdiploid stemline (DNA index = 1.1) with low proliferative activity. Differentiation between clinically indolent and aggressive carcinomas may be possible by nuclear DNA determination, but further work is needed to determine the importance of proliferative activity in thyroid carcinoma.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3966895     DOI: 10.1001/archotol.1985.00800030068008

Source DB:  PubMed          Journal:  Arch Otolaryngol        ISSN: 0003-9977


  12 in total

Review 1.  The utility of some modern techniques in understanding thyroid pathology.

Authors:  Virginia A LiVoisi
Journal:  Endocr Pathol       Date:  1990-06       Impact factor: 3.943

2.  The adrenal cortex in ectopic adrenocorticotropic hormone syndrome: A morphological study with histology, transmission and scanning electron microscopy, flow cytometry, and image analysis.

Authors:  Kwok H Li; Sylvia L Asa; Kalman Kovacs; David Murray; William Singer
Journal:  Endocr Pathol       Date:  1990-09       Impact factor: 3.943

Review 3.  The study of endocrine tumors by flow and image cytometry.

Authors:  Ingrid Zbieranowski; David Murray
Journal:  Endocr Pathol       Date:  1992-06       Impact factor: 3.943

4.  Flow cytometric DNA measurements in benign and malignant Hürthle cell tumors of the thyroid.

Authors:  J J Ryan; I D Hay; C S Grant; L M Rainwater; G M Farrow; J R Goellner
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

5.  Flow cytometric DNA analysis of thyroid carcinoma.

Authors:  A Tsuchiya; K Sekikawa; Y Ando; S Suzuki; I Kimijima; R Abe
Journal:  Jpn J Surg       Date:  1990-09

6.  Reproducibility of flow cytometric assessment of follicular tumours of the thyroid.

Authors:  T P van Thiel; J C van der Linden; J P Baak; M M van de Sandt; C van Galen; P D Bezemer
Journal:  J Clin Pathol       Date:  1989-03       Impact factor: 3.411

7.  DNA aneuploidy in follicular adenomas of the thyroid gland.

Authors:  H Joensuu; P Klemi; E Eerola
Journal:  Am J Pathol       Date:  1986-09       Impact factor: 4.307

8.  18F-fluorodeoxyglucose imaging in preoperative diagnosis of thyroid malignancy.

Authors:  H Joensuu; A Ahonen; P J Klemi
Journal:  Eur J Nucl Med       Date:  1988

9.  Diagnostic and prognostic utility of flow cytometric DNA measurements in follicular thyroid tumors.

Authors:  C S Grant; I D Hay; J J Ryan; E J Bergstralh; L M Rainwater; J R Goellner
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

10.  Proliferation Markers and Their Uses in the Study of Endocrine Tumors.

Authors:  Giuseppe Pelosi; Giuseppe Zamboni
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.